US President Joe Biden tested positive for COVID-19 this Thursday, and the White House announced that he is taking the Paxlovid medicine. It is a drug produced by the pfizer pharmaceutical and recommended by the World Health Organization (WHO) to treat early stages of COVID-19 disease in patients at risk of hospitalization, such as the elderly, immunosuppressed or unvaccinated.
The Paxlovid actually consists of two drugs, nirmatrelvir and ritonavir. The first is an antiviral y the second is a pharmacokinetic enhancer. It is only recommended for adults and adolescents 12 years and older.
One of the greatest exponents of the fight against the pandemic in the United States, and Biden’s main health adviser, Anthony Fauci, recommended its use after having used the drug during his contagion, in mid-June last.
“Paxlovid did what it was supposed to do,” Fauci, 81, said in a recent interview after riding through the disease uneventfully.
The oral antiretroviral drug from the Pfizer laboratory is administered in the early stages of the disease, when serious symptoms have not yet developed. One tablet is taken orally every 24 hours for five days. According to the WHO, it is indicated for,“patients with non-severe forms of COVID-19 who run a high risk of progressing to severe forms of the disease and being hospitalized, such as unvaccinated, elderly or immunosuppressed patients“.
In June a controversy broke out when Pfizer suspended trials in less vulnerable patients detecting that Paxlovid was not effective in them, however the WHO expresses its great concern that – as happened with vaccines against COVID-19 – low- and middle-income countries are again relegated to the back of the queue in accessing this treatment.
Get the latest news in your email
Everything you need to know to start your day
Registering implies accepting the Terms and Conditions